+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Recombinant Human Ciliary Neurotrophic Factor Market - Global Forecast 2025-2030- Product Image
Recombinant Human Ciliary Neurotrophic Factor Market - Global Forecast 2025-2030- Product Image
Sale

Recombinant Human Ciliary Neurotrophic Factor Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6137661
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The recombinant human ciliary neurotrophic factor market is evolving rapidly as biotechnology and pharmaceutical companies intensify efforts to advance neuroprotective and regenerative therapies. Senior decision-makers are prioritizing scalable production, strategic collaborations, and regulatory readiness to realize emerging opportunities in neurology, ophthalmology, and research domains.

Market Snapshot: Recombinant Human Ciliary Neurotrophic Factor

Recombinant human ciliary neurotrophic factor (rhCNTF) has positioned itself as a key biomolecule in neurotherapeutic research. Precision synthesis using recombinant DNA technology ensures high-quality production standards, supporting both therapeutic and diagnostic applications. Recent advances in gene editing and bioprocess engineering have improved expression efficiencies and downstream processing, facilitating broader clinical translation and accelerating time-to-market for novel applications. Stakeholders in North America, Europe, Middle East & Africa, and Asia-Pacific are driving research initiatives and manufacturing capacity through targeted public and private investment strategies.

Scope & Segmentation

This report provides a comprehensive analysis across essential segments, regions, and technologies influencing the recombinant human ciliary neurotrophic factor landscape.

  • Application Segments: Neurology (Alzheimer’s disease, motor neuron disease, Parkinson’s disease), Ophthalmology (corneal injuries, optic nerve degeneration, retinal diseases), and Research (academic and contract projects)
  • End User Categories: Clinics, contract research organizations, hospitals, research institutes
  • Product Grades: Diagnostic grade, GMP grade, research grade
  • Distribution Channels: Direct sales, online channels, third-party distributors
  • Regional Coverage: Americas (United States – California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Technological Focus: Expression vector optimization, gene editing, advanced bioprocess engineering, delivery systems crossing blood-brain and blood-retinal barriers

Key Takeaways for Industry Leaders

  • Continued optimization in expression vectors and process engineering is enabling robust yields and high-purity preparations of rhCNTF.
  • Innovators are increasingly adopting next-generation delivery modalities designed to improve tissue targeting and minimize immunogenicity in both neurological and ocular settings.
  • Collaboration between academic, biopharmaceutical, and contract manufacturing organizations is accelerating the translation of preclinical findings into clinical impact across priority disease areas.
  • Responsive regulatory frameworks—such as adaptive trial designs and accelerated approval pathways—are encouraging entry into areas of high unmet medical need.
  • Diversification of distribution strategies (including online portals and direct relationships) enhances supply chain resilience while addressing diverse end-user preferences.
  • Major regional clusters, particularly in North America and Asia-Pacific, are driving capacity expansion and accelerating delivery of investigational rhCNTF products to market.

Tariff Impact: Navigating 2025 U.S. Supply Chain Pressures

Recent 2025 United States tariff measures are increasing input and logistics costs for recombinant human ciliary neurotrophic factor manufacturers, especially for growth media and purification resins. Organizations are mitigating risks through long-term sourcing agreements, revisited manufacturing footprints, and enhanced cold-chain logistics. Adopting process intensification and engaging trade experts are helping offset input cost increases and ensure consistent product availability.

Methodology & Data Sources

The research supporting this analysis incorporates extensive secondary reviews of peer-reviewed journals, patent filings, and regulatory documents. Targeted primary interviews were conducted with scientists, manufacturing specialists, and regulatory consultants. Triangulation of qualitative insights was matched with quantitative assessments such as cost structure analysis and process yield evaluation to validate key findings at every stage.

Why This Report Matters

  • Enables informed, evidence-based executive decisions for market entry, product development, or clinical strategy in rhCNTF segments.
  • Delivers actionable competitive intelligence on technological and regulatory shifts directly impacting biopharmaceutical stakeholders.
  • Provides deep segmentation and regional insights to help senior leaders target growth areas effectively and respond rapidly to changing industry conditions.

Conclusion

This report offers a strategic blueprint for decision-makers navigating the recombinant human ciliary neurotrophic factor market. Adopting optimized technology, fostering robust partnerships, and responding swiftly to regulatory and supply chain developments will underpin future leadership in neurotherapeutic innovation.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing clinical adoption of rhCNTF eye drop formulations for retinal degeneration therapy
5.2. Emerging gene therapy vectors designed for sustained and targeted rhCNTF ocular release
5.3. Strategic partnerships forging collaborations between biotech firms and academia for rhCNTF innovation
5.4. Regulatory milestones achieved in Phase II and III trials evaluating rhCNTF for optic neuropathy
5.5. Innovations in nanoparticle and liposomal carriers enhancing rhCNTF stability and corneal penetration
5.6. Growing venture capital and private equity investment in rhCNTF candidate portfolios across emerging markets
5.7. Advancements in biomarker-driven patient selection improving efficacy outcomes for rhCNTF clinical studies
5.8. Integration of artificial intelligence platforms optimizing formulation development and delivery of rhCNTF products
5.9. Clinical evidence emerging on rhCNTF neuroprotective effects in age-related macular degeneration patient cohorts
5.10. Emerging competitive landscape analysis highlighting key market entrants developing rhCNTF therapies globally
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Recombinant Human Ciliary Neurotrophic Factor Market, by Application
8.1. Introduction
8.2. Neurology
8.2.1. Alzheimer Disease
8.2.2. Motor Neuron Disease
8.2.3. Parkinson Disease
8.3. Ophthalmology
8.3.1. Corneal Injuries
8.3.2. Optic Nerve Degeneration
8.3.3. Retinal Diseases
8.4. Research
8.4.1. Academic Research
8.4.2. Contract Research
9. Recombinant Human Ciliary Neurotrophic Factor Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Contract Research Organizations
9.4. Hospitals
9.5. Research Institutes
10. Recombinant Human Ciliary Neurotrophic Factor Market, by Product
10.1. Introduction
10.2. Diagnostic Grade
10.3. Gmp Grade
10.4. Research Grade
11. Recombinant Human Ciliary Neurotrophic Factor Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Online Channels
11.4. Third Party Distributors
12. Americas Recombinant Human Ciliary Neurotrophic Factor Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Recombinant Human Ciliary Neurotrophic Factor Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Recombinant Human Ciliary Neurotrophic Factor Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific
15.3.2. Merck KGaA
15.3.3. Danaher Corporation
15.3.4. Bio-Techne Corporation
15.3.5. Lonza Group AG
15.3.6. Abcam plc
15.3.7. GenScript Biotech Corporation
15.3.8. Takara Bio Inc.
15.3.9. Qiagen N.V.
15.3.10. Agilent Technologies Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET: RESEARCHAI
FIGURE 24. RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET: RESEARCHSTATISTICS
FIGURE 25. RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET: RESEARCHCONTACTS
FIGURE 26. RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ALZHEIMER DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ALZHEIMER DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY MOTOR NEURON DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY MOTOR NEURON DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY CORNEAL INJURIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY CORNEAL INJURIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPTIC NERVE DEGENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPTIC NERVE DEGENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RETINAL DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RETINAL DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY CONTRACT RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY CONTRACT RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DIAGNOSTIC GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DIAGNOSTIC GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY GMP GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY GMP GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 97. CANADA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. CANADA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. CANADA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 100. CANADA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 101. CANADA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 102. CANADA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 103. CANADA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 104. CANADA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 105. CANADA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. CANADA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. CANADA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 108. CANADA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 109. CANADA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. CANADA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. MEXICO RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. MEXICO RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. MEXICO RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 114. MEXICO RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 115. MEXICO RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 116. MEXICO RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 117. MEXICO RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 118. MEXICO RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 119. MEXICO RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. MEXICO RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. MEXICO RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 122. MEXICO RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 123. MEXICO RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. MEXICO RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. GERMANY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. GERMANY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. GERMANY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 186. GERMANY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 187. GERMANY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 188. GERMANY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 189. GERMANY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 190. GERMANY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 191. GERMANY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. GERMANY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. GERMANY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 194. GERMANY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 195. GERMANY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. GERMANY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. FRANCE RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. FRANCE RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. FRANCE RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 200. FRANCE RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 201. FRANCE RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 202. FRANCE RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 203. FRANCE RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 204. FRANCE RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 205. FRANCE RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. FRANCE RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. FRANCE RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 208. FRANCE RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 209. FRANCE RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. FRANCE RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. ITALY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. ITALY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. ITALY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 228. ITALY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 229. ITALY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 230. ITALY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 231. ITALY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 232. ITALY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 233. ITALY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. ITALY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. ITALY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 236. ITALY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 237. ITALY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. ITALY RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. SPAIN RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. SPAIN RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. SPAIN RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 242. SPAIN RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 243. SPAIN RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 244. SPAIN RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 245. SPAIN RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 246. SPAIN RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 247. SPAIN RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. SPAIN RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. SPAIN RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 250. SPAIN RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 251. SPAIN RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. SPAIN RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEU

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Recombinant Human Ciliary Neurotrophic Factor market report include:
  • Thermo Fisher Scientific
  • Merck KGaA
  • Danaher Corporation
  • Bio-Techne Corporation
  • Lonza Group AG
  • Abcam plc
  • GenScript Biotech Corporation
  • Takara Bio Inc.
  • Qiagen N.V.
  • Agilent Technologies Inc.

Related Topics

Related Reports

Human Ciliary Neurotrophic Factor Market - Global Forecast 2025-2030 - Product Image

Human Ciliary Neurotrophic Factor Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Rat Brain Dopamine Neurotrophic Factor Reagent Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Rat Brain Dopamine Neurotrophic Factor Reagent Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Neuroregeneration Therapy - Global Strategic Business Report - Product Image

Neuroregeneration Therapy - Global Strategic Business Report

  • Report
  • 480 Pages
  • Global
From
Primary Ciliary Dyskinesia (PCD) - Pipeline Insight, 2025 - Product Image

Primary Ciliary Dyskinesia (PCD) - Pipeline Insight, 2025

  • Clinical Trials
  • 40 Pages
  • Global
From
Neuroprotection Therapeutics - Global Strategic Business Report - Product Image

Neuroprotection Therapeutics - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.